Cargando…

Efficacy and safety of probiotic-supplemented bismuth quadruple therapy for the treatment of Helicobacter pylori infection: a systematic review and meta-analysis

OBJECTIVE: We performed a meta-analysis to determine whether the addition of probiotics to the bismuth quadruple therapy (BQT) for Helicobacter pylori would improve the incidence of eradication and reduce that of side effects. METHODS: Randomized controlled trials matching the inclusion criteria wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Gaoyan, Fan, Xiaoyuan, Lu, Dewen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Meta Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586011/ https://www.ncbi.nlm.nih.gov/pubmed/37848344 http://dx.doi.org/10.1177/03000605231203841

Ejemplares similares

The efficacy and safety of furazolidone-bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotic supplementation
por: Noorbakhsh, Nafeh, et al.
Publicado: (2022)

High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of helicobacter pylori infection: A meta-analysis of randomized controlled trials
por: Zhang, Chong, et al.
Publicado: (2023)

Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta analysis
por: Xie, Ya-Lin, et al.
Publicado: (2020)

Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis
por: Losurdo, Giuseppe, et al.
Publicado: (2018)

Probiotics in 14-day triple therapy for Asian pediatric patients with Helicobacter pylori infection: a network meta-analysis
por: Wen, Juanjuan, et al.
Publicado: (2017)

Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis
por: Wang, Zheyu, et al.
Publicado: (2022)

Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori
por: Wang, Junxian, et al.
Publicado: (2021)

Association of Barrett’s esophagus with Helicobacter pylori infection: a meta-analysis
por: Ma, Shaoze, et al.
Publicado: (2022)

Fourth-generation quinolones in the treatment of Helicobacter pylori infection: A meta-analysis
por: An, Ying, et al.
Publicado: (2018)

Meta-analysis of the correlation between Helicobacter pylori infection and autoimmune thyroid diseases
por: Hou, Yi, et al.
Publicado: (2017)

The endoscopic predictors of Helicobacter pylori status: a meta-analysis of diagnostic performance
por: Glover, Ben, et al.
Publicado: (2020)

Association between Helicobacter pylori and end-stage renal disease: A meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2017)

Is there an association between Helicobacter pylori infection and irritable bowel syndrome? A meta-analysis
por: Ng, Qin Xiang, et al.
Publicado: (2019)

Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis
por: Si, Xiao-Bei, et al.
Publicado: (2019)

Helicobacter pylori infection and peptic ulcer disease in cirrhotic patients: An updated meta-analysis
por: Wei, Lin, et al.
Publicado: (2021)

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
por: Gisbert, Javier P, et al.
Publicado: (2012)

Susceptibility-guided bismuth quadruple therapies for resistant Helicobacter pylori infections
por: Yang, Tiankuo, et al.
Publicado: (2020)

Is Helicobacter pylori Associated Functional Dyspepsia Correlated With Dysbiosis?
por: Kim, Yeon-Ji, et al.
Publicado: (2017)

Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
por: Jheng, Guang-Hong, et al.
Publicado: (2015)

Is Helicobacter pylori infection associated with pancreatic cancer? A systematic review and meta-analysis of observational studies
por: Zhou, Ben-Gang, et al.
Publicado: (2023)

Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
por: Alsohaibani, Fahad, et al.
Publicado: (2020)

Effect of gastric microbiota on quadruple Helicobacter pylori eradication therapy containing bismuth
por: Niu, Zhan-Yue, et al.
Publicado: (2021)

Helicobacter pylori Infection is Associated with Occurrence of Proteinuria in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis
por: Shi, Yan, et al.
Publicado: (2018)

Polymerase chain reaction-based tests for detecting Helicobacter pylori clarithromycin resistance in stool samples: A meta-analysis
por: Gong, Ren-Jie, et al.
Publicado: (2021)

Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant Helicobacter pylori strains: A network meta-analysis
por: Zou, Shu-Peng, et al.
Publicado: (2022)

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
por: Huh, Ki Young, et al.
Publicado: (2021)

Empirical versus tailored therapy based on genotypic resistance detection for Helicobacter pylori eradication: a systematic review and meta-analysis
por: Li, Meng, et al.
Publicado: (2023)

Efficacy of Twice a Day Bismuth Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection
por: Kim, Jeemyoung, et al.
Publicado: (2022)

Helicobacter pylori recurrence after eradication in Latin America: Implications for gastric cancer prevention
por: Corral, Juan E, et al.
Publicado: (2017)

Effects of probiotic and synbiotic supplementation on insulin resistance in women with polycystic ovary syndrome: a meta-analysis
por: Miao, Chenyun, et al.
Publicado: (2021)

Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
por: Kim, Sung Eun, et al.
Publicado: (2017)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
por: Niu, Min, et al.
Publicado: (2022)

Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori
por: Zhang, Lingyun, et al.
Publicado: (2019)

Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant Helicobacter pylori Infection: Effectiveness and Cost-Efficiency
por: Lee, Moon Won, et al.
Publicado: (2022)

Lactobacillus rhamnosus GG supplementation on eradication rate and dyspepsia in Helicobacter pylori infection treated with three-in-one bismuth quadruple therapy
por: Marinelli, Paride, et al.
Publicado: (2022)

Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: An updated meta-analysis
por: Zhou, Xin-Die, et al.
Publicado: (2019)

Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease
por: Wu, Mei-Yi, et al.
Publicado: (2017)

Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis
por: Sun, Jian-Rong, et al.
Publicado: (2019)

Efficacy and Safety of Acupuncture for Essential Hypertension: A Meta-Analysis
por: Chen, Hao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_43d6tc1m83ml5b2pr065ajng6k